The Cigna Group (NYSE:CI) Shares Bought by Goldstein Advisors LLC

Goldstein Advisors LLC grew its stake in The Cigna Group (NYSE:CIFree Report) by 25.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,083 shares of the health services provider’s stock after purchasing an additional 220 shares during the period. Goldstein Advisors LLC’s holdings in The Cigna Group were worth $299,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CI. Benjamin F. Edwards & Company Inc. grew its position in The Cigna Group by 1.4% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,206 shares of the health services provider’s stock worth $729,000 after purchasing an additional 31 shares during the last quarter. AE Wealth Management LLC lifted its stake in shares of The Cigna Group by 7.1% in the 2nd quarter. AE Wealth Management LLC now owns 3,812 shares of the health services provider’s stock worth $1,260,000 after acquiring an additional 252 shares during the period. 1832 Asset Management L.P. lifted its stake in shares of The Cigna Group by 6.2% in the 2nd quarter. 1832 Asset Management L.P. now owns 4,299 shares of the health services provider’s stock worth $1,421,000 after acquiring an additional 252 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of The Cigna Group by 14.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 984 shares of the health services provider’s stock worth $343,000 after acquiring an additional 125 shares during the period. Finally, Public Sector Pension Investment Board lifted its stake in shares of The Cigna Group by 68.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 11,003 shares of the health services provider’s stock worth $3,637,000 after acquiring an additional 4,471 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Trading Up 0.2 %

Shares of CI stock opened at $289.04 on Thursday. The stock has a market cap of $80.40 billion, a price-to-earnings ratio of 27.27, a price-to-earnings-growth ratio of 0.78 and a beta of 0.54. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The firm’s 50 day moving average price is $298.30 and its two-hundred day moving average price is $326.03.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The firm had revenue of $63.70 billion for the quarter, compared to analysts’ expectations of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The Cigna Group’s revenue was up 29.8% compared to the same quarter last year. During the same period in the previous year, the company posted $6.77 earnings per share. On average, analysts anticipate that The Cigna Group will post 28.5 EPS for the current year.

Analysts Set New Price Targets

CI has been the subject of several recent analyst reports. Piper Sandler reiterated an “overweight” rating and issued a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Barclays raised their target price on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Stephens restated an “overweight” rating and set a $410.00 target price on shares of The Cigna Group in a report on Friday, November 1st. Finally, Royal Bank of Canada lowered their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a report on Friday, November 1st. One analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $395.93.

Get Our Latest Research Report on The Cigna Group

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.